FTO levels were frequently observed to be downregulated in HCC, particularly in patients experiencing HCC recurrence, suggesting a potential implication of FTO in HCC metastasis and recurrence via modulation of m6A modification. Here, FTO is linked to hepatocellular carcinoma.